[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ueki et al., 2019 - Google Patents

Severe Eosinophilic Disorders: Mechanisms and Clinical Management

Ueki et al., 2019

Document ID
5327632361653120301
Author
Ueki S
Akuthota P
Neves J
Publication year

External Links

Snippet

Eosinophils have intrigued physicians and scientists alike since the time of their first report in 1879. While lower numbers in systemic circulation (< 0.5× 109/L) are generally considered healthy (1), increased peripheral numbers and, more importantly, tissue accumulation is …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Mukherjee et al. Eosinophil extracellular traps and inflammatory pathologies—untangling the web!
Ueki et al. Allergic bronchopulmonary aspergillosis–a luminal hypereosinophilic disease with extracellular trap cell death
Brinkmann Neutrophil extracellular traps in the second decade
Ramirez et al. Eosinophils from physiology to disease: a comprehensive review
Yousefi et al. In vivo evidence for extracellular DNA trap formation
Livraghi et al. Cystic fibrosis and other respiratory diseases of impaired mucus clearance
Ueki et al. Eosinophil ETosis and DNA traps: a new look at eosinophilic inflammation
Cicko et al. Extracellular ATP is a danger signal activating P2X7 receptor in a LPS mediated inflammation (ARDS/ALI)
Lee et al. Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function?
Vorobjeva et al. Neutrophil extracellular traps: mechanisms of formation and role in health and disease
Boufenzer et al. Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
Dias et al. Identification of piecemeal degranulation and vesicular transport of MBP-1 in liver-infiltrating mouse eosinophils during acute experimental Schistosoma mansoni infection
Eguíluz‐Gracia et al. Monocytes accumulate in the airways of children with fatal asthma
Magnadóttir et al. Extracellular vesicles from cod (Gadus morhua L.) mucus contain innate immune factors and deiminated protein cargo
Conese Cystic fibrosis and the innate immune system: therapeutic implications
Ueki et al. Severe Eosinophilic Disorders: Mechanisms and Clinical Management
Mihlan et al. Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay
Gwin et al. Gamma secretase activating protein promotes end-organ dysfunction after bacterial pneumonia
Singh The great obstruction The mechanism of neutrophil extracellular trap (NET) formation and their role in occlusive disorders
Kastratovic et al. Effects of combustible cigarettes and heated tobacco products on immune cell-driven inflammation in chronic obstructive respiratory diseases
Klomp Interferon-γ Mediates Lung Damage through the Hyper-Activation of CCR2+ Inflammatory Monocytes during Influenza Virus Infection
KORKMAZ C5aR1 functions in cellular networking of ILC2 in health and
Shrestha et al. Biomedical Sciences, Iowa State University, Ames, Iowa 50011
Teixeira Alves The deleterious role of neutrophil extracellular traps (NETs) in pneumococcal pneumonia and therapeutic treatment with adrenomedullin
Alves The deleterious role of neutrophil extracellular traps (NETs) in pneumococcal pneumonia and therapeutic treatment with adrenomedullin